Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug

Plus news about AusperBio and Samsung Biologics. Eli Lilly’s Mounjaro wins heart approval: The blockbuster drug, whose generic name is tirzepatide, was approved on Friday to reduce the risk of major ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 28 August →